Increase in serum ceruloplasmin levels is correlated with a decrease of serum nitric oxide levels in type 2 diabetes

被引：19

作者：

Daimon, M

Sugiyama, K

Saitoh, T

Yamaguchi, H

Hirata, A

Ohnuma, H

Igarashi, M

Eguchi, H

Manaka, H

Kato, T

机构：

[1] Yamagata Univ, Sch Med, Dept Internal Med 3, Yamagata 9909585, Japan

[2] Yamagata Saisei Hosp, Dept Internal Med, Yamagata, Japan

来源：

DIABETES CARE | 2000年 / 23卷 / 04期

关键词：

D O I：

10.2337/diacare.23.4.559

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：559 / 560

页数：2

共 6 条

[1] PATHOPHYSIOLOGY OF ATHEROSCLEROSIS [J].

CHOBANIAN, AV .

AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (17) :G3-G7

[2] Hyperglycemia is a factor for an increase in serum ceruloplasmin in type 2 diabetes [J].

Daimon, M ;

Hama, K ;

Susa, S ;

Kimura, M ;

Yamatani, K ;

Ohnuma, H ;

Manaka, H ;

Kato, T .

DIABETES CARE, 1998, 21 (09) :1525-1528

[3]

Danks D.M., 1995, METABOLIC MOL BASIS, P2211

[4] INTACT HUMAN CERULOPLASMIN OXIDATIVELY MODIFIES LOW-DENSITY-LIPOPROTEIN [J].

EHRENWALD, E ;

CHISOLM, GM ;

FOX, PL .

JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (04) :1493-1501

[5] OXIDIZED LOW-DENSITY-LIPOPROTEIN DECREASES THE EXPRESSION OF ENDOTHELIAL NITRIC-OXIDE SYNTHASE [J].

LIAO, JK ;

SHIN, WS ;

LEE, WY ;

CLARK, SL .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (01) :319-324

[6] Endothelial dysfunction and atherosclerosis [J].

Vanhoutte, PM .

EUROPEAN HEART JOURNAL, 1997, 18 :E19-E29

← 1 →